— Know what they know.
Not Investment Advice

PBLA OTC

Panbela Therapeutics, Inc.
1W: +0.0% 1M: +11000.0% 3M: +122.0% YTD: -15.3% 1Y: -77.8% 3Y: -100.0% 5Y: -100.0%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 62 · $53889 mcap · 5M float · 0.020% daily turnover · Short 48% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 2Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
0
Earnings Quality
30
Growth
—
Value
15
Momentum
—
Safety
0
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-60.75
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✗ ✓ ✗ ✓ ✗ ✗ ✓
Beneish M-Score
—
—
Ohlson O-Score
36.68
Bankruptcy prob: 100.0%
High Risk
Credit Rating
CCC
Score: 12.9/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.56x
Accruals: -156.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PBLA scores -60.75, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PBLA scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PBLA's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PBLA receives an estimated rating of CCC (score: 12.9/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
-0.00x
P/S
0.00x
P/B
-0.01x
P/FCF
-0.11x
P/OCF
—
EV/EBITDA
-0.30x
EV/Revenue
—
EV/EBIT
-0.29x
EV/FCF
-0.51x
Earnings Yield
-1616.83%
FCF Yield
-902.31%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. PBLA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.994
NI / EBT
×
Interest Burden
1.023
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
-0.765
Assets / Equity
=
ROE
270.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PBLA's ROE of 270.3% is driven by A tax burden ratio of 0.99 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.01
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
1179.7%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Jennifer K. Simpson
President and Chief Executive Officer
$506,000 $— $694,324
Susan Horvath Financial
ancial Officer and Vice President of Finance
$320,000 $— $423,459

CEO Pay Ratio

1:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $694,324
Avg Employee Cost (SGA/emp): $629,125
Employees: 8

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
8
+14.3% YoY
Revenue / Employee
—
Profit / Employee
$-3,157,875
NI: $-25,263,000
SGA / Employee
$629,125
Avg labor cost proxy
R&D / Employee
$2,576,750
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
ROE -7.5% -94.4% -6.2% -81.5% -97.0% -1.3% -1.9% -64.9% -1.1% -1.6% -59.2% -13.0% -32.3% -8.0% 1115.6% 4.4% 4.0% 83.7% 9.9% 2.7% 2.70%
ROA -2.5% -3.2% -2.0% -63.6% -73.6% -94.8% -1.3% -56.8% -89.3% -1.2% -4.5% -3.4% -3.9% -2.6% -1.5% -3.0% -3.0% -2.0% -2.0% -3.5% -3.53%
ROIC 3.6% -14.4% -15.4% 3.6% 7.9% 10.7% 12.7% 10.7% 4.8% -11.0% 46.5% 10.7% 10.8% -11.1% -5.5% -13.8% 12.6% -37.4% 4.6% 2.4% 2.40%
ROCE -3.2% -7.9% -3.1% -53.9% -59.7% -72.9% -1.3% -61.2% -1.0% -1.8% -89.0% 10.9% 12.2% -5.4% -2.2% -13.6% 48.7% -3413.1% 3.9% 1.8% 1.83%
Gross Margin 2.0% — — — 1.0% — — — 2.0% — — — 2.0% — — — — — — — —
Operating Margin 52.5% — — — -1.2% — — — 2.7% — — — 3.1% — — — — — — — —
Net Margin 40.8% — — — -67.9% — — — 2.9% — — — 2.9% — — — — — — — —
EBITDA Margin 43.9% — — — 61.3% — — — 2.7% — — — 3.2% — — — — — — — —
FCF Margin 1.1% 1.3% 1.4% 1.5% -3.0% -3.6% -4.3% -4.7% 5.5% 7.6% 9.7% 9.8% 9.3% 12.5% 13.5% 16.6% — — — — —
OCF Margin 1.1% 1.3% 1.4% 1.5% -3.0% -3.6% -4.3% -4.7% 5.5% 7.6% 9.7% 9.8% 9.3% 12.5% 13.5% 16.6% — — — — —
ROA 3Y Avg snapshot only -4.85%
ROIC Economic snapshot only 2.43%
Cash ROA snapshot only -3.01%
Valuation
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
P/E Ratio -89.78 -108.45 -146.78 -97.60 -144.11 -7.47 -4.08 -3.86 -2.30 -2.46 -0.31 -0.17 -0.07 -0.09 -0.08 -0.16 -171.93 -0.08 -0.07 -0.06 -0.000
P/S Ratio -232.83 -291.09 -280.31 -198.51 530.18 30.14 22.04 22.24 -19.13 -23.35 -7.96 -4.62 -1.48 -2.11 -1.03 -2.33 — — — — 0.000
P/B Ratio 402.11 961.71 419.07 49.73 81.33 5.15 4.84 2.14 2.28 4.31 -2.00 -0.68 -0.30 1.36 0.35 -1.54 -921.74 -0.66 -0.18 -0.09 -0.007
P/FCF -203.33 -226.36 -203.12 -131.42 -178.28 -8.31 -5.16 -4.70 -3.47 -3.08 -0.82 -0.47 -0.16 -0.17 -0.08 -0.14 -171.94 -0.08 -0.10 -0.11 -0.111
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -127.70 -118.83 -128.77 -86.09 -191.18 -8.45 -4.08 -2.51 -1.14 -1.93 -0.27 -0.22 -0.14 -0.06 0.02 -0.34 -172.69 -0.22 -0.22 -0.30 -0.302
EV/Revenue -231.85 -290.89 -279.75 -194.02 523.21 23.89 17.10 11.39 -9.37 -18.63 -11.51 -9.48 -4.88 -2.08 0.20 -4.95 — — — — —
EV/EBIT -125.47 -122.35 -135.10 -90.13 -134.38 -5.60 -2.97 -1.79 -1.07 -1.90 -0.44 -0.34 -0.23 -0.09 0.02 -0.35 -172.92 -0.22 -0.21 -0.29 -0.291
EV/FCF -202.48 -226.21 -202.71 -128.45 -175.94 -6.59 -4.00 -2.41 -1.70 -2.45 -1.19 -0.96 -0.52 -0.17 0.01 -0.30 -172.05 -0.24 -0.30 -0.51 -0.512
Earnings Yield -1.1% -0.9% -0.7% -1.0% -0.7% -13.4% -24.5% -25.9% -43.6% -40.7% -3.3% -6.0% -14.4% -10.5% -11.9% -6.2% -0.6% -13.0% -14.7% -16.2% -16.17%
FCF Yield -0.5% -0.4% -0.5% -0.8% -0.6% -12.0% -19.4% -21.3% -28.8% -32.5% -1.2% -2.1% -6.3% -6.0% -13.1% -7.1% -0.6% -11.9% -10.4% -9.0% -9.02%
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Current Ratio 1.76 1.48 1.90 5.91 7.15 6.75 5.20 11.01 4.62 1.76 0.56 0.22 0.23 0.80 1.02 0.21 0.25 0.17 0.05 0.26 0.257
Quick Ratio 1.76 1.48 1.90 5.91 7.15 6.75 5.20 11.01 4.62 1.76 0.56 0.22 0.23 0.80 1.02 0.21 0.25 0.17 0.05 0.26 0.257
Debt/Equity 0.08 1.15 0.57 0.01 0.00 0.00 0.00 0.00 0.00 0.25 -1.41 -0.83 -0.85 2.05 1.08 -2.09 -1.10 -1.32 -0.40 -0.35 -0.352
Net Debt/Equity -1.68 -0.64 -0.85 -1.12 -1.07 -1.07 -1.09 -1.05 -1.16 -0.87 — — — -0.02 -0.42 — — — — — —
Debt/Assets 0.04 0.39 0.27 0.01 0.00 0.00 0.00 0.00 0.00 0.15 1.04 1.41 1.37 0.32 0.27 0.49 0.44 0.40 0.45 1.24 1.237
Debt/EBITDA -0.03 -0.14 -0.17 -0.03 -0.00 -0.00 -0.00 -0.00 -0.00 -0.14 -0.13 -0.13 -0.12 -0.09 -0.26 -0.22 -0.21 -0.15 -0.15 -0.24 -0.242
Net Debt/EBITDA 0.54 0.08 0.26 1.99 2.54 2.21 1.18 2.39 1.19 0.49 -0.08 -0.11 -0.10 0.00 0.10 -0.18 -0.10 -0.14 -0.15 -0.24 -0.237
Interest Coverage -2.01 -4.88 -275.17 -286.06 -315.38 -368.67 -496.60 -588.29 -1176.78 -1323.67 -1508.14 -316.02 -121.12 -93.47 -45.13 -54.87 -79.75 -98.93 -107.45 -43.12 -43.123
Equity Multiplier 2.27 2.95 2.08 1.20 1.16 1.17 1.24 1.10 1.26 1.68 -1.36 -0.59 -0.62 6.50 4.07 -4.28 -2.51 -3.30 -0.89 -0.28 -0.284
Cash Ratio snapshot only 0.007
Debt Service Coverage snapshot only -41.514
Cash to Debt snapshot only 0.022
FCF to Debt snapshot only -2.436
Defensive Interval snapshot only 6.0 days
Efficiency & Turnover
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Asset Turnover -0.95 -1.18 -1.03 -0.31 0.20 0.23 0.24 0.10 -0.11 -0.12 -0.18 -0.12 -0.18 -0.12 -0.13 -0.21 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover -6.90 — — — 3.79 6.01 4.15 4.64 -3.77 -3.05 -2.47 -4.02 -8.85 -7.91 -5.93 -16.30 0.00 0.00 0.00 0.00 0.000
Payables Turnover 6.59 10.01 15.10 19.20 7.24 10.16 10.16 10.98 13.23 4.05 15.24 10.80 19.32 5.27 2.18 2.56 3.24 3.47 2.61 3.31 3.307
DSO -53 -0 -0 -0 96 61 88 79 -97 -120 -148 -91 -41 -46 -62 -22 — — — — —
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 55 36 24 19 50 36 36 33 28 90 24 34 19 69 167 143 113 105 140 110 110.4 days
Cash Conversion Cycle — — — — 46 25 52 45 — — — — — — — — — — — — —
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue 13.8% 13.8% 13.8% 13.8% 1.5% 1.5% 1.5% 1.5% -1.9% -1.9% -1.9% -1.9% -34.8% -34.8% -34.8% -34.8% 1.0% 1.0% 1.0% 1.0% 1.00%
Net Income -3.4% -10.2% 18.6% 19.7% 23.1% 18.6% -53.1% -53.4% -1.1% -1.2% -3.5% -3.5% -2.5% -2.2% 36.2% 30.3% 27.7% 25.1% -42.2% -18.7% -18.69%
EPS 20.9% 15.7% 38.7% 38.8% 47.2% -9.9% -19.4% -17.2% -29.5% -62.3% -2.1% -1.9% -39.2% 86.4% 98.9% 99.6% 100.0% 99.7% 98.9% 96.4% 96.44%
FCF -14.7% -19.1% -49.0% -78.1% -40.7% -52.8% -67.7% -69.7% -73.9% -96.3% -1.1% -95.1% -1.3% -1.2% -88.4% -1.3% -65.3% -21.2% 8.9% 42.7% 42.69%
EBITDA -21.5% -1.0% -91.0% -63.1% 18.3% 37.4% -4.6% -9.3% -1.8% -2.2% -8.6% -8.1% -4.5% -3.8% 62.2% 55.3% 54.6% 51.5% -39.7% -10.4% -10.40%
Op. Income -11.9% -44.4% -44.7% -45.7% -32.9% -46.3% -69.3% -52.8% -73.5% -69.2% -2.8% -2.9% -2.4% -2.0% 36.8% 2.1% 1.7% -1.3% -92.8% -14.7% -14.74%
OCF Growth snapshot only 42.69%
Asset Growth snapshot only -51.37%
Debt Growth snapshot only 23.10%
Shares Change snapshot only 32.31%
Growth (CAGR)
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue 3Y — — — — — — — — — — — — — — — — — — — — —
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — -10.8% 20.9% 95.7% 1.3% 69.5% 67.5% 1.5% 89.3% 79.7% 69.8% 8.4% 16.6% 97.6% 80.5% -2.6% 6.3% 5.8% 8.9% -29.6% -29.58%
Assets 5Y — — — — — — — — — 29.8% 28.4% 26.0% 45.4% 55.3% 66.0% 62.3% 44.1% 40.7% 47.7% 6.2% 6.23%
Equity 3Y — 28.9% — — — — 2.8% — 2.4% — — — — 51.8% 44.2% — — — — — —
Book Value 3Y — 1.3% — — — — 6.9% — 5.6% — — — — 14.1% -22.8% — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue Stability 0.87 0.13 0.13 0.13 0.89 0.89 0.89 0.89 0.35 0.00 0.00 0.00 0.38 0.38 0.38 0.38 0.14 0.14 0.14 0.14 0.141
Earnings Stability 0.71 0.25 0.76 0.99 0.77 0.05 0.15 0.22 0.01 0.36 0.38 0.38 0.39 0.53 0.50 0.56 0.64 0.68 0.67 0.66 0.655
Margin Stability — — — — — — — — — — — — — — — — — — — — —
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 1.00 1.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.99 0.96 0.93 0.92 0.91 0.93 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.86 0.88 0.89 0.90 0.83 0.93 0.925
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — 12.87 — — 0.97 1.53 3.03 — — — -13.13 — — — — — — —
Gross Margin Trend — — — — — — — — — — — — — — — — — — — — —
FCF Margin Trend — — — — — — — — — — — — — — — — — — — — —
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
OCF/Net Income 0.44 0.48 0.72 0.74 0.81 0.90 0.79 0.82 0.66 0.80 0.37 0.35 0.44 0.56 1.10 1.16 1.00 0.91 0.70 0.56 0.558
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.558
CapEx/Revenue -0.0% -0.0% -0.0% -0.0% 0.0% 0.0% 0.0% 0.0% -0.0% -0.0% -0.0% -0.1% -0.0% -0.0% -0.0% -0.1% — — — — —
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -1.37 -1.65 -0.54 -0.16 -0.14 -0.10 -0.27 -0.10 -0.30 -0.23 -2.85 -2.21 -2.20 -1.15 0.15 0.47 -0.00 -0.18 -0.58 -1.56 -1.561
Sloan Accruals snapshot only -1.135
Dividends & Buybacks
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.2% 0.1% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.6% -0.5% -0.5% -2.0% -1.4% -26.6% -36.3% -35.0% -43.4% -31.9% -93.6% -0.1% -2.2% -6.0% -16.9% -7.4% -0.6% -9.8% -6.6% -7.4% -7.43%
Total Shareholder Return -0.6% -0.5% -0.5% -2.0% -1.4% -26.6% -36.3% -35.0% -43.4% -31.9% -93.6% -0.1% -2.2% -6.0% -16.9% -7.4% -0.6% -9.8% -6.6% -7.4% -7.43%
DuPont Factors
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Tax Burden (NI/EBT) 0.94 0.94 0.92 0.94 0.94 0.94 0.94 0.90 0.95 0.97 0.99 1.00 1.00 1.00 0.99 0.99 0.99 0.99 0.99 0.99 0.994
Interest Burden (EBT/EBIT) 1.50 1.21 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.02 1.02 1.01 1.01 1.01 1.02 1.023
EBIT Margin 1.85 2.38 2.07 2.15 -3.89 -4.27 -5.75 -6.35 8.72 9.80 26.07 27.57 21.22 22.03 12.12 14.20 — — — — —
Asset Turnover -0.95 -1.18 -1.03 -0.31 0.20 0.23 0.24 0.10 -0.11 -0.12 -0.18 -0.12 -0.18 -0.12 -0.13 -0.21 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 3.05 29.76 3.14 1.28 1.32 1.33 1.42 1.14 1.22 1.41 13.02 3.79 8.25 3.02 -725.22 -1.44 -1.32 -41.48 -5.02 -0.76 -0.765
Per Share
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
EPS (Diluted TTM) $-1122.71 $-1161.78 $-814.26 $-740.15 $-592.89 $-12687.43 $-16630.94 $-13485.66 $-18082.63 $-20585.86 $-51551.98 $-38963.18 $-25165.10 $-2794.44 $-547.69 $-161.33 $-0.11 $-8.72 $-5.88 $-5.75 $-5.75
Book Value/Share $250.68 $131.02 $285.20 $1452.76 $1050.48 $18408.55 $14034.29 $24321.16 $18239.81 $11746.78 $-7923.52 $-9561.50 $-5798.69 $194.73 $130.97 $-17.04 $-0.02 $-1.02 $-2.18 $-3.74 $-1.51
Tangible Book/Share $250.68 $131.02 $285.20 $1452.76 $1050.48 $18408.55 $14034.29 $24321.16 $18239.81 $11746.78 $-7923.52 $-9561.50 $-5798.69 $194.73 $130.97 $-17.04 $-0.02 $-1.02 $-2.18 $-3.74 $-3.74
Revenue/Share $-432.94 $-432.86 $-426.38 $-363.91 $161.15 $3145.77 $3081.74 $2341.25 $-2170.13 $-2168.72 $-1989.89 $-1403.22 $-1180.05 $-125.83 $-44.67 $-11.24 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-495.75 $-556.64 $-588.41 $-549.67 $-479.23 $-11405.83 $-13163.98 $-11073.96 $-11974.12 $-16460.84 $-19204.45 $-13813.87 $-11005.18 $-1578.12 $-602.43 $-186.45 $-0.11 $-7.96 $-4.15 $-3.21 $-8.08
OCF/Share $-495.75 $-556.64 $-588.41 $-549.67 $-479.23 $-11405.83 $-13163.98 $-11073.96 $-11974.12 $-16460.84 $-19204.45 $-13812.72 $-11005.18 $-1578.12 $-602.43 $-186.45 $-0.11 $-7.96 $-4.15 $-3.21 $-8.08
Cash/Share $443.26 $234.53 $403.74 $1653.73 $1121.86 $19656.18 $15230.37 $25421.33 $21195.83 $13183.66 $4143.55 $1086.77 $925.74 $402.14 $196.51 $6.22 $0.01 $0.08 $0.01 $0.03 $0.82
EBITDA/Share $-786.02 $-1059.67 $-926.32 $-820.12 $-441.05 $-8890.91 $-12923.82 $-10640.39 $-17852.23 $-20974.98 $-85322.73 $-61799.21 $-39897.03 $-4331.46 $-537.08 $-164.10 $-0.11 $-8.75 $-5.67 $-5.44 $-5.44
Debt/Share $21.00 $150.74 $162.03 $21.30 $0.00 $0.00 $0.00 $0.00 $0.00 $2945.17 $11208.88 $7904.20 $4930.58 $398.99 $141.66 $35.64 $0.02 $1.34 $0.86 $1.32 $1.32
Net Debt/Share $-422.26 $-83.79 $-241.71 $-1632.44 $-1121.86 $-19656.18 $-15230.37 $-25421.33 $-21195.83 $-10238.49 $7065.33 $6817.43 $4004.83 $-3.15 $-54.85 $29.42 $0.01 $1.26 $0.85 $1.29 $1.29
Academic Models
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -60.750
Altman Z-Prime snapshot only -147.280
Piotroski F-Score 5 4 5 5 5 6 6 5 2 1 1 1 1 1 4 3 5 3 2 3 3
Beneish M-Score — — — — — — — — — — — — — — — — — — — — —
Ohlson O-Score snapshot only 36.683
Net-Net WC snapshot only $-3.74
Credit
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Credit Rating snapshot only CCC
Credit Score 59.62 54.31 55.97 61.72 68.15 67.15 38.28 66.62 34.88 26.39 14.67 12.72 12.80 16.24 20.85 12.74 20.00 12.84 12.75 12.88 12.875
Credit Grade snapshot only 17
Credit Trend snapshot only 0.134
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 1
Sector Credit Rank snapshot only 1

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms